DRA. MARIA ELENA MEDINA-MORA ICAZA



Formación académica:

  • 1993 –  Doctorado en Psicología social, Universidad Nacional Autónoma de México.
  • 1979 – Maestría en Psicología, Universidad Ibero Americana.
  • 1976 – Licenciatura en Psicología, Universidad Ibero Americana.

Nombramientos académicos: 

  • Jefa del Departamento de Psiquiatría y Salud Mental Facultad de Medicina-Universidad Nacional Autónoma de México.
  • Investigadora afiliada al Centro de Investigación en Salud Mental Global, Instituto Nacional de Psiquiatría RFM / Universidad Nacional Autónoma de México
  • Investigadora Emérita -Comisión Coordinadora de los Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Secretaría de Salud
  • Investigadora Nacional Emérita-Sistema Nacional de Investigadores

Líneas de investigación:

  • Estudio de diagnóstico poblacional de salud mental y adicciones.
  • Evaluación de Modelos de Intervención.

Proyectos destacados:

  • CONACYT, Iniciativa de Salud Mental de la OMS2000 Trastornos mentales en México: Trastornos mentales y adicciones, necesidades de atención y utilización de servicios. (2000- a la fecha)
  • NIDA RO1 Adapting and testing an efficacious drug prevention intervention with and for youth in Mexico (CoPI). (En curso)
  • ICD-11 Beta Phase Field Testing. Disorders due to substance use and addictive behaviours. Protocol for service -based field testing of ICD-11:Public Health/Clinical Utility and Comparability with ICD-10 (Phase I) Working Group for Field Testing of Disorders due to Substance Use and related Health Conditions Version 18 February 2019 (En curso)
  • Dissemination of an efficacious youth prevention program in Mexico: scalability and sustainability” GCSO 2019 Grant Program UNAM(Facultad de Psicología) Universidad de Arizona 2019. (En curso)

Selección de publicaciones

  • María Elena Medina Mora, Maristela Monteiro, Robin Room, Jürgem Rehm, David Jernigan, Diego Sanchez Moreno, Tania Rea, (2016) Alcohol Use and Alcohol Use Disorders in Mental, Neurological and substance use disorders. En: Patel, V., Chisholm, D., Dua, T., Lazminarayan, R., Medina-Mora, ME  Editors (2015). Disease Control Priorities Third Edition 4. Mental, Neurological, and Substance Use Disorders. Third Edition 4. Editors: Editorial: World Bank Group., DOI: 10.1596/978-1-46480426-7. Hardcover: 2015.
  • Vikram Patel*, Dan Chisholm*, Rachana Parikh, Fiona J Charlson, Louisa Degenhardt, Tarun Dua, Alize J Ferrari, Steve Hyman, Ramanan Laxminarayan, Carol Levin, Crick Lund, María Elena Medina Mora, Inge Petersen, James Scott, Rahul Shidhaye, Lakshmi Vijayakumar, Graham Thornicroft, Harvey Whiteford, (2016). Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities. The Lancet, 387(10028), 1672-1685.
  • Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton J, Chisholm D, Medina Mora ME, et al (2018) The Lancet Commission on global mental health and sustainable development  The Lancet,  27;392 (10157):1553-1598. doi: 10.1016/S0140-6736(18)31612-X. Epub 2018 Oct 9.
  • Reed GM, Keeley JW, Rebello TJ, First MB, Gureje O, Ayuso-Mateos JL, Kanba S, Khoury B, Kogan CS, Krasnov VN, Maj M, de Jesus Mari J, Sharan P, Stein DJ, Zhao M, Akiyama T, Andrews HF, Asevedo E, Cheour M, Domínguez-Martínez T, El-Khoury J, Fiorillo A, Grenier J, Gupta N, Kola L, Kulygina M, Leal-Leturia I, Luciano M, Lusu B, Martínez-López JNI, Matsumoto C, Odunleye M, Onofa LU, Paterniti S, Purnima S, Robles R, Sahu MK, Sibeko G, Zhong N, Gaebel W, Lovell AM, Maruta T, Pike KM, Roberts MC, Medina-Mora ME. Clinical utility of ICD-11 diagnostic guidelines for high-burden mental disorders: results from mental health settings in 13 countries. World Psychiatry. 2018 Oct;17(3):306-315.
  • Borges G, Benjet C, Orozco R, Medina-Mora ME. A longitudinal study of reciprocal risk between mental and substance use disorders among Mexican youth. J Psychiatr Res. 2018 Aug 10;105:45-53.
  • María Elena Medina-Mora, Rebeca Robles, Tahilia J. Rebello, Tecelli Domínguez, Nicolás Martínez, Francisco Juárez, Pratap Sharan, Geoffrey M. Reed: “ICD-11 guidelines for psychotic, mood, anxiety andstress-related disorders in Mexico: Clinical utility and reliability”. España.  International Journal of Clinical and Health Psychology, 19:1-11, 2019. ISSN: 1697-2600.
  • David Goodman-Meza, Maria Elena Medina-Mora, Carlos Magis-Rodríguez, Raphael J. Landovitz, Steve Shoptaw, Dan Werb: “Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US – Mexico Border”. Am J Public Health, 109:73–82, 2019.
  • Marsiglia FF, Medina-Mora ME, Gonzalvez A, Alderson G, Harthun M, Ayers S, Nuño B, Corona MD, and Mendoza MA.(2019). Binational cultural adaptation of the keepin’ it REAL substance use prevention program for adolescents in Mexico. Prevention Science https://doi.org/10.1007/s11121-019-01034-0-Ref ID: 1645
  • Nora D. Volkow, María Elena Medina-Mora Icaza, Vladimir Poznyak, Shekhar Saxena, Gilberto Gerra, and the UNODC- WHO Informal Scientific Network  Addressing the opioid crisis globally   World Psychiatry 18:2 – 231-232,  June 2019.
  • Borges (a1), S. Aguilar-Gaxiola (a2), L. Andrade (a3), C. Benjet (a1), A. Cia (a4), R. C. Kessler (a5), R. Orozco (a1), N. Sampson (a5), J. C. Stagnaro (a6), Y. Torres (a7), Maria Carmen Viana (a8) and M. E. Medina-Mora (a1) Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys Epdemilogy and Psychiatric Sciences https://doi.org/10.1017/S2045796019000477, Published online by Cambridge University Press.